Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative
Background: Isorhapontigenin (trans–3,5,4′-trihydroxy–3′–methoxystilbene, ISO), a dietary resveratrol (trans–3,5,4′–trihydroxystilbene) derivative, possesses various health-promoting activities. To further evaluate its medicinal potentials, the pharmacokinetic and metabolomic profiles of ISO were ex...
Main Authors: | Yu Dai, Samuel C. M. Yeo, Peter J. Barnes, Louise E. Donnelly, Lai C. Loo, Hai-Shu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00753/full |
Similar Items
-
Piceatannol and Its Metabolite, Isorhapontigenin, Induce SIRT1 Expression in THP-1 Human Monocytic Cell Line
by: Shinpei Kawakami, et al.
Published: (2014-10-01) -
Oxyresveratrol: A bioavailable dietary polyphenol
by: Wan Chen, et al.
Published: (2016-04-01) -
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
by: Panxia Wang, et al.
Published: (2021-03-01) -
Pterostilbene surpassed resveratrol for anti-inflammatory application: Potency consideration and pharmacokinetics perspective
by: Qiu-Yi Choo, et al.
Published: (2014-11-01) -
Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway
by: Zhe Xue, et al.
Published: (2021-07-01)